Improving support and self-management of ophthalmic patients using an artificial intelligence health coach
Indian Journal of Ophthalmology · 2026-04 · 74 (4) · 584-588
DOI: 10.4103/ijo.ijo_2205_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, online erschienen am 26.03.2026. Verfasst von Ojasvi Sharma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom. Hauptthemen laut MEDLINE: Artificial Intelligence, Self-Management, Eye Diseases, Mentoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Künstliche Intelligenz in der Pflege, Selbstmanagement bei chronischen Erkrankungen
Abstract (Originalsprache)
This study evaluates patient engagement and satisfaction with Everyday Medical Monitoring Ally (E.M.M.A), a purpose-trained artificial intelligence (AI)-powered health coach delivered via WhatsApp. E.M.M.A integrates AI-driven symptom tracking, personalized medical information, and lifestyle guidance to support eye health management in a real-world clinical setting. This pilot study enrolled patients from a UK-based ophthalmology clinic managing chronic eye conditions. Patient interactions with E.M.M.A were logged over a 2-month period. Data collected included chat frequency, temporal patterns, and interaction modality (text or audio). A post-study satisfaction survey was conducted. Human validation of AI-generated question–answer pairs was performed independently by two glaucoma consultants. Ninety-one patients consented to participate, of whom 83 interacted with E.M.M.A, generating 446 analyzed chat sessions. Audio interactions accounted for 28% of chats. A subgroup of 39 users (42%) generated nearly 75% of all chats, while 52% of users were repeat users. Most patient queries related to general eye health and symptoms, comprising 39% of questions. Symptom-related content accounted for 26% of response classifications. The satisfaction survey was completed by 66 users, with 88% reporting being satisfied or very satisfied. A total of 65% would definitely recommend E.M.M.A, while 9% reported mild to moderate anxiety during use. Human expert validation scores exceeded 95% across all assessed domains. Qualitative feedback indicated acceptance of E.M.M.A as a reassuring and valuable adjunct when immediate clinical support was unavailable. AI-driven health coaches such as E.M.M.A may help bridge gaps in ophthalmic care between clinical visits by providing continuous, personalized, and medical record-informed patient support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom.
- Department of Medicine, University of Manchester, Manchester, United Kingdom.
- Community Ophthalmology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, Delhi, India.
- Department of AI, Neurance AI, Bengaluru, Karnataka, India.
Zitieren
APA
Sharma, O., Sharma, B., Gupta, V., Bakshi, A., Gupta, R., Dada, T., & Sharma, T. (2026). Improving support and self-management of ophthalmic patients using an artificial intelligence health coach. Indian Journal of Ophthalmology, 74(4), 584-588. https://doi.org/10.4103/ijo.ijo_2205_25
Vancouver
Sharma O, Sharma B, Gupta V, Bakshi A, Gupta R, Dada T, et al. Improving support and self-management of ophthalmic patients using an artificial intelligence health coach. Indian Journal of Ophthalmology. 2026;74(4):584-588. doi:10.4103/ijo.ijo_2205_25
BibTeX
@article{Sharma2026,
author = {Sharma, Ojasvi and Sharma, Bhavesh and Gupta, Vivek and Bakshi, Ajay and Gupta, Rohit and Dada, Tanuj and Sharma, Tarun},
title = {Improving support and self-management of ophthalmic patients using an artificial intelligence health coach},
journal = {Indian Journal of Ophthalmology},
year = {2026},
volume = {74},
number = {4},
pages = {584--588},
doi = {10.4103/ijo.ijo_2205_25}
}
EUVIMED